NCT07374445CompletedPhase 4
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
The Timing for Liraglutide in Patients Remaining Obese at 6 Months After Metabolic Surgery: an Observational Study
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to compare the weight loss and metabolic benefit in patients remaining obesity at 6 months after metabolic surgery. The main questions it aims to answer are: \[primary hypothesis 1\] Whether liraglutide benefits weight loss when it is initiated early after metabolic surgery. \[primary hypothesis 2\] Whether weight loss and metabolic benefits are greater when linaglutide is initiated in patients who are obese at 6 months after metabolic surgery
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 1 Sept 2025
- Start date
- 1 Sept 2023
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Diseases
- Obesity
- NCT number
- NCT07374445
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 100
- From 1 Sept 2023 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- history of medullary thyroid carcinoma, MEN-2 or other malignancies
- pancreatitis or severe gastrointestinal disease, pregnancy or lactation
- use of anti-obesity drugs or other interventional trials within 3 months or major uncontrolled illness
Lab values
- allergy to liraglutide, severe hepatic or renal impairment (eGFR \<60 mL/min/1.73 m² or ALT/AST ≥3× ULN)
Other
- Patients were discontinued if withdrawn, intolerant, lost to follow-up, or developed severe adverse events.
Who the study is looking for
- Patients 6 months after metabolic surgery;
- 18 years ≤ age ≤ 65 years;
- Body Mass Index (BMI) ≥ 28 kg/m\^2
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nanjing Drum Tower hospital Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.